登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C17H14F3N3O2S
化学文摘社编号:
分子量:
381.37
UNSPSC Code:
41116107
NACRES:
NA.24
MDL number:
grade
pharmaceutical primary standard
Quality Level
API family
celecoxib
form
solid
shelf life
limited shelf life, expiry date on the label
manufacturer/tradename
BP
application(s)
pharmaceutical
pharmaceutical small molecule
format
neat
storage temp.
2-8°C
SMILES string
Cc1ccc(cc1)-c2cc(nn2-c3ccc(cc3)S(N)(=O)=O)C(F)(F)F
InChI
1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)
InChI key
RZEKVGVHFLEQIL-UHFFFAOYSA-N
Gene Information
human ... PTGS2(5743)
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Celecoxib BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.
Also used in monographs such as:Celecoxib Capsules
Also used in monographs such as:
Biochem/physiol Actions
塞来昔布是一种非甾体类抗炎药 (NSAID) 和环氧化酶-2 (COX-2) 选择性抑制剂。塞来昔布对 COX-2 的选择性至少是 COX-1 的 10-20 倍。
塞来昔布是一种非甾体类抗炎药 (NSAID) 和环氧化酶-2 (COX-2) 选择性抑制剂。
Packaging
Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
Other Notes
Sales restrictions may apply.
Still not finding the right product?
Explore all of our products under 塞来昔布
signalword
Danger
hcodes
Hazard Classifications
Aquatic Chronic 1 - Repr. 1B - STOT RE 2
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| BP1230 | 04061841294221 |